359 related articles for article (PubMed ID: 16162694)
1. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma.
Szefler S; Rohatagi S; Williams J; Lloyd M; Kundu S; Banerji D
Chest; 2005 Sep; 128(3):1104-14. PubMed ID: 16162694
[TBL] [Abstract][Full Text] [Related]
2. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
[TBL] [Abstract][Full Text] [Related]
3. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma.
Lipworth BJ; Kaliner MA; LaForce CF; Baker JW; Kaiser HB; Amin D; Kundu S; Williams JE; Engelstaetter R; Banerji DD
Ann Allergy Asthma Immunol; 2005 Apr; 94(4):465-72. PubMed ID: 15875528
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma.
Xu J; Nave R; Lahu G; Derom E; Derendorf H
J Clin Pharmacol; 2010 Oct; 50(10):1118-27. PubMed ID: 20150524
[TBL] [Abstract][Full Text] [Related]
5. Lower-leg growth rates in children with asthma during treatment with ciclesonide and fluticasone propionate.
Agertoft L; Pedersen S
Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 2):e199-205. PubMed ID: 19320851
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma.
Pedersen S; Garcia Garcia ML; Manjra A; Theron I; Engelstätter R
Pediatr Pulmonol; 2006 Oct; 41(10):954-61. PubMed ID: 16868976
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids: A comparison of ciclesonide and fluticasone propionate.
Kaliner MA
Clin Ther; 2006 Mar; 28(3):319-31. PubMed ID: 16750447
[TBL] [Abstract][Full Text] [Related]
8. Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses.
Affrime MB; Kosoglou T; Thonoor CM; Flannery BE; Herron JM
Chest; 2000 Dec; 118(6):1538-46. PubMed ID: 11115437
[TBL] [Abstract][Full Text] [Related]
9. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
Lee DK; Haggart K; Currie GP; Bates CE; Lipworth BJ
Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
[TBL] [Abstract][Full Text] [Related]
10. Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma.
Derom E; Louis R; Tiesler C; Engelstätter R; Kaufman JM; Joos GF
Eur Respir J; 2009 Jun; 33(6):1277-86. PubMed ID: 19164356
[TBL] [Abstract][Full Text] [Related]
11. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.
Sorkness CA; LaForce C; Storms W; Lincourt WR; Edwards L; Rogenes PR
Clin Ther; 1999 Feb; 21(2):353-67. PubMed ID: 10211538
[TBL] [Abstract][Full Text] [Related]
12. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
Bateman ED; Linnhof AE; Homik L; Freudensprung U; Smau L; Engelstätter R
Pulm Pharmacol Ther; 2008; 21(2):264-75. PubMed ID: 17604664
[TBL] [Abstract][Full Text] [Related]
13. Potential effects of fluticasone propionate on bone mineral density in patients with asthma: a 2-year randomized, double-blind, placebo-controlled trial.
Kemp JP; Osur S; Shrewsbury SB; Herje NE; Duke SP; Harding SM; Faulkner K; Crim CC
Mayo Clin Proc; 2004 Apr; 79(4):458-66. PubMed ID: 15065610
[TBL] [Abstract][Full Text] [Related]
14. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
Derom E; Van De Velde V; Marissens S; Engelstätter R; Vincken W; Pauwels R
Pulm Pharmacol Ther; 2005; 18(5):328-36. PubMed ID: 15939311
[TBL] [Abstract][Full Text] [Related]
15. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
Ringdal N; Lundbäck B; Alton M; Rak S; Eivindson A; Bratten G; Kjaersgaard P
Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
[TBL] [Abstract][Full Text] [Related]
16. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
Hansel TT; Benezet O; Kafé H; Ponitz HH; Cheung D; Engelstätter R; Barnes PJ
Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
[TBL] [Abstract][Full Text] [Related]
17. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function.
Sheth KK; Cook CK; Philpot EE; Prillaman BA; Witham LA; Faris MA; Klein KC; Rickard KA
Allergy Asthma Proc; 2004; 25(2):115-20. PubMed ID: 15176496
[TBL] [Abstract][Full Text] [Related]
18. Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis.
Li JT; Goldstein MF; Gross GN; Noonan MJ; Weisberg S; Edwards L; Reed KD; Rogenes PR
J Allergy Clin Immunol; 1999 Apr; 103(4):622-9. PubMed ID: 10200011
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler.
Kosoglou T; Hubbell J; Cutler DL; Johnson-Levonas AO; Xu D; Kantesaria BS; Kim K; Miller SD
Chest; 2013 Dec; 144(6):1795-1802. PubMed ID: 24077095
[TBL] [Abstract][Full Text] [Related]
20. Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.
Lee DK; Bates CE; Currie GP; Cowan LM; McFarlane LC; Lipworth BJ
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):253-8. PubMed ID: 15478385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]